103.208 articles found

Simvastatin attenuates disease phenotypes in human induced pluripotent stem cell models of familial Parkinson’s disease through RhoA inhibition

Schmidt SI, Okarmus J, Ryding M, Skousen IK, Jensen NFB, Christensen EB, Winkelmann LS, Juhl AD, Klæbel M, Blaabjerg M, Freude K, Wüstner D, Wade-Martins R, Ryan B, Meyer M.

· 2026-08-31

DOI: 10.64898/2026.08.26.747232

The LRRK2 R1441G+M1646T haplotype is associated with slower motor symptom progression in Parkinson’s disease

Check source for author details

medRxiv · 2026-08-31

Subthalamic stimulation modulates working memory-related cortical dynamics in Parkinson's disease.

Keute M, Wang T, Miranda Montenegro S, Scherer M, Bookjans P, Brunnett B, Cebi I, Milosevic L, Weiss D, Gharabaghi A.

Brain Commun · 2026-08-31

DOI: 10.1093/braincomms/fcag328PMID: 42712895

Real-world deep brain stimulation programming practices for Parkinson's disease in India: variability, technology adoption, and emerging trends from a multicentre clinician survey across India.

Pal PK, Rajan R, Krishnan Nair S, Yadav R, Anand M, Balakrishnan S, Baldia M, Banarjee AD, Borgohain R, Ganguly J, Ginjupally DR, Holla VV, Hosurkar G, Kamble N, Kandadai RM, Kayal A, Kohat AK, Kumar H, Mahale RR, Matur V, Prasad S, Shiva Kumar R, Sheikh A, Shetty K, Singh S, Venkatachalam A, Shankar V, Vysakh KV, Yareeda S.

Front Neurol · 2026-08-31

DOI: 10.3389/fneur.2026.1892612PMID: 42741162

A validated workflow for paired total and small RNA sequencing from low-input submandibular gland biopsy specimens in <i>de novo</i> Parkinson's disease patients.

Choi KE, Kim JS.

Front Aging Neurosci · 2026-08-31

DOI: 10.3389/fnagi.2026.1931183PMID: 42741392

Inflammation and neuropsychiatric symptoms in Parkinson's disease: a genetic association.

Gonçalves AR, Mendes A, Damásio J, Vila-Chã N, Boleixa D, Santos C, Leal B, Cavaco S.

Front Aging Neurosci · 2026-08-31

DOI: 10.3389/fnagi.2026.1877657PMID: 42741404

Advances in nanomaterial-based biomarker detection for neurodegenerative diseases: Special focus on Alzheimer's and Parkinson's disease.

Azeez S, Chinnadurai RK, Ponne S, Duraikannu D.

Int Rev Neurobiol · 2026-08-31

DOI: 10.1016/bs.irn.2026.07.004PMID: 42785895

Rapidly Progressive Dementia and Parkinsonism Secondary to Intracranial Dural Arteriovenous Fistula in a 60-year-old Male: A Case Report.

Baya PMHA, Osayan AAA, Saranza GRM, Villamor RBV.

Acta Med Philipp · 2026-08-31

DOI: 10.47895/amp.v60i16.13504PMID: 42920852

Multitargeted drug strategies for Alzheimer's and Parkinson's diseases.

Khan AU, Abdullah A, Naqvi SF, Tahir H, Khalid H, Sarfraz H, Khan Y.

Z Naturforsch C J Biosci · 2026-08-31

DOI: 10.1515/znc-2026-0116PMID: 42666058

Harnessing the neuroprotective potential of estrogen in Parkinson's disease: an insight into molecular mechanisms and therapeutic approaches.

Kaur A, Sharma A, Upadhayay S.

Metab Brain Dis · 2026-08-31

DOI: 10.1007/s11011-026-01969-8PMID: 42671470

Associations Between Objective, Functional, and Self-Reported Balance Assessments and Fall Frequency in Parkinson's Disease.

Duzenli̇ S, Yildirim AA, Gunduz MS, Ozyilmaz S, Yeldan I, Poyraz M, Erdal Y.

Ir J Med Sci · 2026-08-31

DOI: 10.1007/s11845-026-04596-5PMID: 42671749

VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Bentall LM, Parr-Brownlie LC.

Neuroscience · 2026-08-31

DOI: 10.1016/j.neuroscience.2026.08.050PMID: 42674206